Ambu A/S (OTCMKTS:AMBBY) Hits New 12-Month Low – What’s Next?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) hit a new 52-week low on Thursday . The company traded as low as $11.11 and last traded at $11.11, with a volume of 100 shares. The stock had previously closed at $11.7350.

Ambu A/S Price Performance

The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $2.61 billion, a PE ratio of 35.84 and a beta of 0.98. The stock has a 50-day moving average of $13.04 and a 200 day moving average of $14.10.

Ambu A/S (OTCMKTS:AMBBY) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. The business had revenue of $242.85 million for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.